NanoMedSyn
Created in 2012
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
611Activities
Technologies
Entity types
Location
Av. Charles Flahault, 34090 Montpellier, France
Montpellier
France
Employees
Scale: 2-10
Estimated: 4
SIREN
789145760Engaged corporates
0
0 0Added in Motherbase
2 years, 1 month ago
biotech Value proposition
NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors
NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism.
NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA.
The main application is the engineering of recombinant proteins like antibodies or enzymes for better therapies.
therapeutis targeting, lysosomal storage diseases, therapeutic antibodies, and nanoparticles adressingOriginal language
NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors
NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism.
NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA.
The main application is the engineering of recombinant proteins like antibodies or enzymes for better therapies.
NanoMedSyn - Therapeutic Proteins Engineering
NanoMedSyn is working on therapeutic targeting. Our targeting pionneer technology involves synthetic derivatives.
https://nanomedsyn.com/
